How can orphan drug manufacturers demonstrate value and improve access to drugs?
Health Technology Assessment
August 15, 2017Share
10/03/2017February 8, 2017
Approval and access: overcoming the final hurdle of drug development
December 23, 2016Share
Experts discuss England’s proposed ‘fast-track’ appraisals for new treatments, plus MAAs.
Fast-track appraisals and Managed Access Agreements
December 22, 2016Share
Experts call for urgent development of new drug funding mechanisms.
High-value, high-cost drugs: how to pay for them
November 3, 2016Share
The prospects for HTA Early Scientific Advice programmes.
Who needs (early) advice? You do!